Event Details
2nd Annual NYS Medical Cannabis Symposium: Cannabinoids in Clinical Practice
Hosted by the New York State Office of Cannabis Management & Northwell Health
November 6–7th, 2025 | Long Island, New York

The New York State Office of Cannabis Management, in collaboration with Northwell Health, proudly presents the 2nd Annual Cannabinoids in Clinical Practice Symposium—the official event of the NYS Medical Cannabis Program.
This symposium serves as a dynamic platform for researchers, healthcare professionals, and trainees to delve into the latest science on cannabis and its therapeutic potential.
Participants will explore cannabinoid pharmacology, discuss emerging clinical applications, and examine the broader health and societal impacts of medical cannabis. The symposium also offers opportunities to engage with leading experts from across New York State, build professional connections, and deepen understanding of the endocannabinoid system’s role in patient care.
Call for Speakers
Share Your Expertise on Cannabinoids in Clinical Practice

The 2nd Annual NYS Medical Cannabis Symposium: Cannabinoids in Clinical Practice is now accepting proposals for oral and poster presentations.
This year’s symposium will highlight the latest in cannabis science, clinical applications, and the evolving role of cannabinoids in patient care. Healthcare professionals, researchers, and trainees are invited to submit proposals featuring current evidence, emerging research, or clinical experiences in medical cannabis.
This is a unique opportunity to share your work, connect with a multidisciplinary audience, and contribute to the ongoing conversation around cannabinoids in healthcare.
To view the scope of last year’s sessions, explore the 2024 Program Booklet.
Submit your proposal using the link below by June 5, 2025.
Suggested Topics Include (but are not limited to):
- Legal and regulatory considerations in medical cannabis
- Biology of the endocannabinoid system
- Cannabis pharmacology and drug interactions
- Routes of administration and dosing
- Therapeutic applications for conditions such as:
- Alzheimer’s disease
- Autism spectrum disorder
- Cancer and cancer-associated symptoms
- Chemotherapy-induced nausea and vomiting
- Chronic pain and neuropathy
- Epilepsy
- HIV/AIDS
- Mental health and mood disorders
- Multiple sclerosis
- Parkinson’s disease
- Palliative care
- Rheumatoid arthritis
- Cannabis Health Equity
- Cannabis and substance use disorder
- Cannabis regulation and public policy
- Cannabis and public health
- Cannabis education
- Social impact of cannabis
- Potential Health Implications and Risks of Medical Cannabis
- Culturally competent cannabis care
Whether you are at the forefront of clinical care or advancing cannabis research, we invite you to share your insights in this year’s program.